Bioheart, Inc.


Bioheart CSO Review

By StemCellCEO Posted on 26th March 2014

The field of regenerative medicine is rapidly developing new therapies to offer hope to patients who previously had very limited options.  Bioheart, founded in 1999, has been at the forefront. Learn More


Mar 7th

bioheart ceo

Dear Bioheart Shareholder and Friends,   First and foremost, THANK YOU from the bottom of my heart for the incredible outpouring of support during my time away from the office. . Learn More

Holiday Greetings From Bioheart CEO Mike Tomas

Jan 1st

Dear Bioheart Shareholders and Friends,   Although not properly reflected by the stock price of recent, Bioheart continues to make great strides towards strengthening our core team and strategic relationships,. Learn More

Clinical Progress and Strategic Initiatives

Oct 3rd


Dear Bioheart Shareholders and Friends, As the 3rd quarter winds down, Bioheart continues to announce new strategic business efforts as well as the progression of our unique stem cell technology.. Learn More

Bioheart Family Grows

Aug 12th

  Dear Bioheart Shareholders and Friends,   As part of our continued growth as a late clinical stage biotechnology company, Bioheart has expanded our team.  These experienced and talented leaders will. Learn More